BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

10276

539276

KAYA

img img img img
No Data Available

KAYA LIMITED performance

Today’s low

Today’s high

₹ 375.90 ₹ 395.75
₹ 395.75

52 week low

52 week high

₹ 204.43 ₹ 487.90
₹ 395.75

Open Price

₹ 384.85

Prev. Close

₹ 359.80

Volume (Shares)

33276.00

Total traded value

₹ 131.68

Upper Circuit

₹ 395.75

Lower Circuit

₹ 323.85

info

KAYA LIMITED Share Price Update

As of the latest trading session, KAYA LIMITED share price is currently at ₹ 395.75, which is up by ₹ 35.95 from its previous closing. Today, the stock has fluctuated between ₹ 375.90 and ₹ 395.75. Over the past year, KAYA LIMITED has achieved a return of -11.59 %. In the last month alone, the return has been -20.36 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KAYA LIMITED fundamentals


  • Market cap (Cr)

    601.00

  • P/E Ratio (TTM)

    -10.14

  • Beta

    1.41

  • Book Value / share

    -60.86

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -18.75

info icon alternate text
  • Market cap (Cr)

    613.00

  • P/E Ratio (TTM)

    -10.14

  • Beta

    1.13

  • Book Value / share

    -60.86

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -18.75

info icon alternate text

KAYA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 53.85
Operating Expense 77.01
Net Profit -18.75
Net Profit Margin (%) -34.81
Earnings Per Share (EPS) -13.17
EBITDA 1.08
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 52.79
Operating Expense 67.47
Net Profit -14.07
Net Profit Margin (%) -26.65
Earnings Per Share (EPS) -10.74
EBITDA 4.34
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 54.69
Operating Expense 66.11
Net Profit -6.97
Net Profit Margin (%) -12.74
Earnings Per Share (EPS) -5.33
EBITDA 10.35
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 58.35
Operating Expense 74.86
Net Profit -15.40
Net Profit Margin (%) -26.39
Earnings Per Share (EPS) -11.77
EBITDA 2.05
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 52.35
Operating Expense 63.96
Net Profit -10.63
Net Profit Margin (%) -20.30
Earnings Per Share (EPS) -8.13
EBITDA 6.62
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 217.42
Operating Expense 260.99
Net Profit -26.51
Net Profit Margin (%) -12.19
Earnings Per Share (EPS) -20.26
EBITDA 41.79
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 210.32
Operating Expense 353.65
Net Profit -138.72
Net Profit Margin (%) -65.95
Earnings Per Share (EPS) -106.18
EBITDA -77.58
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 178.31
Operating Expense 267.65
Net Profit -85.49
Net Profit Margin (%) -47.94
Earnings Per Share (EPS) -65.44
EBITDA -23.77
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 140.91
Operating Expense 175.29
Net Profit -25.48
Net Profit Margin (%) -18.08
Earnings Per Share (EPS) -19.50
EBITDA 20.02
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 117.07
Operating Expense 143.70
Net Profit -14.12
Net Profit Margin (%) -12.06
Earnings Per Share (EPS) -10.81
EBITDA 29.02
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -106.47
ROE % 193.81
ROCE % -0.73
Total Debt to Total Equity 0.00
EBITDA Margin 16.23
Particulars MAR 2024 (Values in Cr)
Book Value / Share -173.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -16.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share -79.41
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -3.77
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.19
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 6.87
EBITDA Margin 9.46
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.70
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.41
EBITDA Margin 15.17
Particulars MAR 2025 (Values in Cr)
Book Value / Share -106.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 14.34
Particulars MAR 2024 (Values in Cr)
Book Value / Share -89.40
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -36.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.04
EBITDA Margin -12.55
Particulars MAR 2022 (Values in Cr)
Book Value / Share 68.98
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.34
EBITDA Margin 16.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.04
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.95
EBITDA Margin 26.04
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.38
Total Assets 236.73
Total Liabilities 236.73
Total Equity -139.45
Share Outstanding 13097541
Price to Book Ratio -2.19
Return on Assets (%) 35.34
Return on Capital (%) 1812.49
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.08
Total Assets 295.45
Total Liabilities 295.45
Total Equity -226.78
Share Outstanding 13064091
Price to Book Ratio -3.51
Return on Assets (%) -43.73
Return on Capital (%) 263.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 53.96
Total Assets 369.95
Total Liabilities 369.95
Total Equity -103.07
Share Outstanding 13064091
Price to Book Ratio 20.84
Return on Assets (%) -31.48
Return on Capital (%) -298.5
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.89
Total Assets 360.99
Total Liabilities 360.99
Total Equity -1.02
Share Outstanding 13064091
Price to Book Ratio 5.08
Return on Assets (%) -19.06
Return on Capital (%) -80.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 12.77
Total Assets 368.03
Total Liabilities 368.03
Total Equity 54.85
Share Outstanding 13064091
Price to Book Ratio 3.80
Return on Assets (%) -10.32
Return on Capital (%) -41.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.62
Total Assets 236.73
Total Liabilities 236.73
Total Equity -139.45
Share Outstanding 13097541
Price to Book Ratio -2.19
Return on Assets (%) -11.19
Return on Capital (%) -574.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.45
Total Assets 220.67
Total Liabilities 220.67
Total Equity -116.79
Share Outstanding 13064091
Price to Book Ratio -3.51
Return on Assets (%) -62.85
Return on Capital (%) -1558.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 15.75
Total Assets 302.74
Total Liabilities 302.74
Total Equity 15.87
Share Outstanding 13064091
Price to Book Ratio 20.84
Return on Assets (%) -28.23
Return on Capital (%) -79.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 7.69
Total Assets 322.82
Total Liabilities 322.82
Total Equity 90.11
Share Outstanding 13064091
Price to Book Ratio 5.08
Return on Assets (%) -7.89
Return on Capital (%) -15.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.46
Total Assets 277.05
Total Liabilities 277.05
Total Equity 101.95
Share Outstanding 13064091
Price to Book Ratio 3.80
Return on Assets (%) -5.09
Return on Capital (%) -11.46
Particulars MAR 2025 (Values in Cr)
Net Income 83.67
Cash from Operations 1.21
Cash from Investing 24.93
Cash from Financing -36.94
Net change in Cash -10.80
Free Cash Flow 30.99
Particulars MAR 2024 (Values in Cr)
Net Income -129.65
Cash from Operations 38.76
Cash from Investing -8.51
Cash from Financing -37.54
Net change in Cash -7.13
Free Cash Flow 74.69
Particulars MAR 2023 (Values in Cr)
Net Income -116.26
Cash from Operations 62.79
Cash from Investing -39.76
Cash from Financing -18.32
Net change in Cash 5.32
Free Cash Flow 87.75
Particulars MAR 2022 (Values in Cr)
Net Income -67.95
Cash from Operations 29.88
Cash from Investing -34.68
Cash from Financing 11.84
Net change in Cash 7.60
Free Cash Flow 45.83
Particulars MAR 2021 (Values in Cr)
Net Income -37.41
Cash from Operations 31.56
Cash from Investing 4.32
Cash from Financing -30.74
Net change in Cash 4.94
Free Cash Flow 34.44
Particulars MAR 2025 (Values in Cr)
Net Income -26.51
Cash from Operations 14.58
Cash from Investing 13.92
Cash from Financing -30.43
Net change in Cash -1.93
Free Cash Flow 42.80
Particulars MAR 2024 (Values in Cr)
Net Income -138.71
Cash from Operations 40.16
Cash from Investing -34.53
Cash from Financing -12.95
Net change in Cash -7.30
Free Cash Flow 70.99
Particulars MAR 2023 (Values in Cr)
Net Income -85.48
Cash from Operations 47.32
Cash from Investing -1.46
Cash from Financing -31.77
Net change in Cash 14.06
Free Cash Flow 63.24
Particulars MAR 2022 (Values in Cr)
Net Income -25.47
Cash from Operations 34.43
Cash from Investing -74.25
Cash from Financing 39.52
Net change in Cash -0.28
Free Cash Flow 44.27
Particulars MAR 2021 (Values in Cr)
Net Income -14.12
Cash from Operations 18.06
Cash from Investing -7.06
Cash from Financing -9.88
Net change in Cash 1.15
Free Cash Flow 18.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6919.80 59.51 10.95 99496.11 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 59.87 24.74 3.26 112.21 55.15 / 98.70
SHREE PACETRONIX LTD. 225.55 37.91 4.83 87.96 61.11 / 283.15
TRANSGENE BIOTEK LTD. 2.95 0.00 2.42 22.35 2.61 / 8.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6919.80 70.98 10.68 99496.11 6002.15 / 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 / 0.0
CHENNAI MEENAKSHI MULTISPECIAL 49.85 0.00 -14.48 37.24 28.34 / 57.48
KOVAI MEDICAL CENTER & HOSPITA 5898.40 28.23 5.42 6452.85 4810.20 / 6725.00

KAYA LIMITED shareholding pattern

Holding

45.41%
51.42%
0.62%
2.52%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

KAYA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
395.75 9.99 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 345.70
  • 26 Days 373.90
  • 10 Days 351.50
  • 50 Days 392.50
  • 12 Days 354.60
  • 100 Days 399.20
  • 20 Days 366.50
  • 200 Days 387.70
330.35 PIVOT

First Support

320.75

First Resistance

336.70

Second Support

314.40

Second Resistance

346.30

Third Support

304.80

Third Resistance

352.65

RSI

25.11

ADX

49.65

MACD

-21.34

Williams % R

-96.35

Commodity Channel Index (CCI)

-127.00

Date

2025-12-18

Week

15625.00

Same Day

3804.00

Month

9377.00

1 Year

1.35

3 Year

0.95

Over 1 Month

-20.36%

down

Over 1 Year

-11.59%

down

Over 3 Months

-22.40%

down

Over 3 Years

0.56%

down

Over 6 Months

-6.26%

down

Over 5 Years

3.46%

down

KAYA LIMITED Corporate Actions

KAYA LIMITED Share Price

Kaya Limited was formerly incorporated as Kaya Skin Care Limited on March 27, 2003. The Company name was changed from Kaya Skin Care Limited to Kaya Limited in March, 2012. The Company, headquartered in Mumbai, carries on Skin Care Business in India and through its subsidiary in Middle East region. Up to March 31, 2013, the Kaya Business was conducted as subsidiaries of Marico Limited. Following the demerger, of Kaya business from Marico Limited in September, 2013 the Kaya Business has been conducted by the Company and its subsidiaries.

Kaya has pioneered into aesthetic dermatology in India and the Middle East. With presence in 26 cities, it has emerged as largest dermatology chain in India, and are also the largest international chain of skincare clinics in Middle East region across the UAE, The Kingdom of Saudi Arabia (KSA) and Oman. The Company business principally comprises the provision of skin care services and products through Kaya Skin Clinics and it operate the brand name of 'Kaya' in India and Middle East by which, 119 clinics were made operational during the year 2014-15. The Clinics offer skin care solutions using scientific dermatological procedures and products.

In 2015, Marico Kaya Enterprises Limited (MaKE) was amalgamated with the Company which came into effect from May 13, 2015 through the Scheme of Arrangement. In terms of the said Scheme, e, the Company allotted 1,28,97,100 fully paid up equity shares of face value of Rs 10 /- each on June 1, 2015 to the entitled shareholders of MaKE in the Share Exchange Ratio of 1:1 on May 27, 2015.

In 2022-23, the Company through its subsidiary company, viz., Kaya Middle East FZE acquired 100% stake in Kaya Trading LLC (UAE); Kaya Skin Care Clinic LLC (UAE); Kaya Skin Care Clinic - Sole Proprietorship LLC (UAE) and Kaya Beauty Clinic - Sole Proprietorship LLC (UAE). Also, a subsidiary viz., Kaya Skin Medical Centre LLC was incorporated by the step-down subsidiary, viz., Kaya Middle East FZE.

In 2024, Company expanded its product range to include Haircare, Nutraceuticals, Bath & Body Solutions, to meet diverse needs of customers. Additionally, it introduced complementary products for services such as post-laser care, body treatments, and comprehensive hair care regimes. The second clinic was launched in Ludhiana in FY25.

Parent organization Indian Private
NSE symbol KAYA
Founded 2003
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kaya Ltd?

Answer Field

Kaya Ltd share price is for NSE ₹ 395.75 & for BSE ₹ 403.60 as on Dec 22 2025 03:19 PM.

What is the Market Cap of Kaya Ltd Share?

Answer Field

The market cap of Kaya Ltd for NSE ₹ 518.33 & for BSE ₹ 528.61 as on Dec 22 2025 03:19 PM.

What is the 52 Week High and Low of Kaya Ltd?

Answer Field

The 52 Week High and Low of Kaya Ltd for NSE is ₹ 487.90 and ₹ 204.43 and for BSE is ₹ 486.90 and ₹ 213.50.

What is 1 year return for Kaya Ltd?

Answer Field

The 1 year returns on the stock has been -4.05%.

What is the P/E Ratio of Kaya Ltd Share?

Answer Field

As on Dec 22 2025 03:19 PM the price-to-earnings (PE) ratio for Kaya Ltd share is -10.14.

What is the PB ratio of Kaya Ltd Share?

Answer Field

As on Dec 22 2025 03:19 PM, the price-to-book (PB) ratio for Kaya Ltd share is -60.86.

How to Buy Kaya Ltd Share?

Answer Field

You can trade in Kaya Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kaya Ltd Share on Bajaj Broking App?

Answer Field

To buy Kaya Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kaya Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59